Chris Lange.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
Top Performing Calls
Coverage
Background
| BA Business | 2011 |
| BBVA · Associate | 2013-2014 |
| TBLA · Director of Operations | 2012-2013 |
Essential Reading
How I Think About Money
- 01 Asset owners will always outpace wage earners, so invest wisely.
- 02 Compound interest is the most powerful force in the world.
Recent Work
14,028 articlesEnterprise Products vs. Williams: Which Pipeline Dividend Wins for Retirees?
Two pipeline giants both raised their payouts this quarter, but one cut its dividend during the last industry bust while the other kept raising through it. For retirees living on portfolio income,…
A $1,000 Investment in Eli Lilly Became $18,637. The Obesity Boom Changed Everything
Eli Lilly spent most of its 150-year history as a quiet insulin maker before a single drug reshuffled the entire obesity market and turned a modest stake into a fortune that left…
Bristol Myers Squibb’s 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know
Bristol Myers Squibb has raised its dividend for 17 straight years, but a looming patent cliff and $43 billion in debt put the pace of future increases on a collision course with…